Showing results (371-380 of 440) with videos related to
Sort By:
Pageof 44
Gastro Hep Advances|December 16, 2025
Patient-Reported Outcome Scores Are Comparable in Multiregional Versus Uniregional Eosinophilic EsophagitisMargaret H Collins, Zhaoxing Pan, Guang-Yu Yang, et al.Journal of Medicinal Chemistry|August 20, 2004
Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activityPing Chen, Arthur M Doweyko, Derek Norris, et al.The Journal of Allergy and Clinical Immunology|August 28, 2020
Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi studyTimothy E Dribin, Hugh A Sampson, Carlos A Camargo, et al.ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid ArthritisSteven H Spergel, Michael E Mertzman, James Kempson, et al.Journal of Medicinal Chemistry|July 18, 2019
Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)Ryan Moslin, Yanlei Zhang, Stephen T Wrobleski, et al.Journal of Medicinal Chemistry|May 10, 1996
Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicityP Chen, P T Cheng, M Alam, et al.Translational Science of Rare Diseases|January 16, 2018
Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)Katherine Cheng, Sandeep K Gupta, Susanna Kantor, et al.The Journal of Allergy and Clinical Immunology|May 16, 2024
Clinical and molecular correlates of the Index of Severity for Eosinophilic EsophagitisHiroki Sato, Evan S Dellon, Seema S Aceves, et al.Journal of Medicinal Chemistry|March 1, 2016
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based SeriesScott H Watterson, Junqing Guo, Steve H Spergel, et al.The Journal of Allergy and Clinical Immunology|January 15, 2019
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"Wendy F Davidson, Donald Y M Leung, Lisa A Beck, et al.Pageof 44